Table 1 Descriptive characteristics of participants of the DLCST at baseline in 2004
From: CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication
Characteristics | Respondents | Intervention | Control | p-value |
|---|---|---|---|---|
N = 4,104 | N = 2,052 | N = 2,052 | ||
Gender, women, number, (%) | 4,104 | 905 (44.10) | 932 (45.42) | 0.397 |
Mean age, years | 4,104 | 57.35 | 57.31 | 0.807 |
Age group (above mean: 57.3 years) (%) | 4,104 | 1,001 (48.78) | 972 (47.37) | 0.365 |
Civic status, living alone, number, (%) | 4,076 | 586 (28.58) | 587 (28.60) | 0.980 |
Mean income per year (DKK) | 4,100 | 316,910 | 315,814 | 0.859 |
SES group, number, (%) | 4,100 | |||
Below 250,000 DKK/year | 754 (36.74) | 759 (36.99) | ||
250–350,000 DKK/year | 650 (31.68) | 643 (31.34) | ||
Above 350,000 DKK/year | 648 (31.58) | 650 (31.68) | 0.972 | |
Charlson co-morbidity index at baseline, number, (%) | 4,104 | |||
0 | 1,717 (83.67) | 1,693 (82.50) | 0.336 | |
1 | 235 (11.45) | 238 (11.60) | ||
>1 | 100 (4.87) | 121 (5.90) | ||
Prescription of AD or AX medication at least once during the 4 months period before baseline, number, (%) | 4,104 | 269 (13.11) | 277 (13.50) | 0.713 |
Prescription of AD or AX medication at least once during the 2 years period before baseline, number, (%) | 4,104 | 483 (23,54) | 502 (24,46) | 0.487 |